Summary
Melanotan I and Setmelanotide sit closest together within the Melanocortin family, which gives them a broadly related biological identity. Their typical research and application settings separate fairly clearly: Melanotan I is more often discussed in the realm of Dermatology and aesthetics, whereas Setmelanotide is more often associated with the realm of Metabolic and endocrine. Mechanistically, both point toward Receptor agonist and converge on Melanocortin receptor, although the downstream emphasis is not identical. Melanotan I has a more synthetic analog origin, while Setmelanotide is closer to synthetic design background and their development context also differs, with Melanotan I approved for Research use only while Setmelanotide is approved. Melanotan I takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide.